Carson W Ercanbrack1, Alexander S Kwok1, Muhammad Z Chauhan1

  • 1Department of Ophthalmology, University of Arkansas for Medical Sciences, Little Rock, USA.

Cureus
|September 16, 2024
PubMed
概括

这项研究突出显示了FGFR抑制剂,用于治疗泌尿器癌的FGFR抑制剂erdafitinib的潜在视网膜毒性. 光学连贯断层扫描 (OCT) 显示了药物停用后消失的特征性变化,这表明OCT可以监测这种副作用.